You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intravenous infusion

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Duchenne Muscular Dystrophy Trial in Chengdu (JWK007 Single intravenous infusion administration)

Recruiting
  • Duchenne Muscular Dystrophy
  • JWK007 Single intravenous infusion administration
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 29, 2023

Postoperative Analgesia Trial in Cairo (Intravenous lidocaine infusion, Erector spinae plane block (ESPB), Intravenous infusion

Not yet recruiting
  • Postoperative Analgesia
  • Intravenous lidocaine infusion
  • +3 more
  • Cairo, Egypt
    Ain-Shams University Hospitals
Oct 13, 2023

Acute Heart Failure, Congestion, Heart Failure Trial in Wroclaw (Furosemide intravenous infusion, Continous intravenous infusion

Recruiting
  • Acute Heart Failure
  • +2 more
  • Furosemide intravenous infusion
  • +2 more
  • Wroclaw, Lower Silesia, Poland
    Institute of Heart Diseases, Wroclaw Medical University
Jul 23, 2023

Pediatric Cancer, Neutropenia, Lenograstim Trial in Taoyuan (G-CSF administration (bolus injection versus intravenous infusion))

Recruiting
  • Pediatric Cancer
  • +4 more
  • G-CSF administration (bolus injection versus intravenous infusion)
  • Taoyuan, ROC, Taiwan
    Chang Gung Children Hospital
Nov 21, 2023

Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing

Not yet recruiting
  • Unresectable Hepatocellular Carcinoma
    • (no location specified)
    Dec 19, 2022

    Intravenous Infusion of Tramadol-ondansetron on Recovery After

    Recruiting
    • Post Operative Pain
    • +8 more
    • Tramadol-ondansetron continuous infusion
    • Ropivacaine via epidural catheter
    • Valencia, Spain
      Hospital Universitario La Fe
    May 26, 2023

    Fomepizole Intravenous Infusion (All-case Surveillance)

    Completed
    • Ethylene Glycol Poisoning, Methanol Poisoning
    • Osaka, Japan
    • +1 more
    Jul 12, 2022

    Hepatitis B Trial (Undiluted I.V.-Hepabig inj(GC5103), Diluted I.V.-Hepabig inj(GC5103))

    Not yet recruiting
    • Hepatitis B
    • Undiluted I.V.-Hepabig inj(GC5103)
    • Diluted I.V.-Hepabig inj(GC5103)
    • (no location specified)
    Jan 19, 2023

    Magnesium Sulfate, Labetalol Trial in Zagazig (Magnesium sulfate, Labetolol)

    Completed
    • Magnesium Sulfate
    • Labetalol
    • Zagazig, Zagazig, Elsharkia,egypt, Egypt
      Faculty of Medicine,Zagazig University
    Nov 13, 2022

    Heart Failure Trial in Vienna (Alprostadil)

    Not yet recruiting
    • Heart Failure
    • Vienna, Austria
      Medical university Vienna
    Oct 28, 2022

    Obinutuzumab, Rapid Infusion, Intravenous Infusion Reaction Trial in Nanjing (intravenous rapid infusion of obinutuzumab)

    Recruiting
    • Obinutuzumab
    • +2 more
    • intravenous rapid infusion of obinutuzumab
    • Nanjing, Jiangsu, China
      Jiangsu Province Hospital
    Aug 18, 2022

    Autism Trial in St. John's (AlloRx)

    Recruiting
    • Autism
    • AlloRx
    • St. John's, Antigua and Barbuda
      Medical Surgical Associates Center
    Oct 25, 2022

    Septic Shock, Sepsis Trial in Cairo (Paracetamol, Normal saline)

    Completed
    • Septic Shock
    • Sepsis
    • Cairo, Egypt
      Cairo University hospitals
    Oct 10, 2023

    Breast Cancer Trial in Saint Petersburg (BCD-178, Perjeta)

    Active, not recruiting
    • Breast Cancer
    • Saint Petersburg, Russian Federation
    • +1 more
    Feb 13, 2023

    Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory

    Active, not recruiting
    • Peripheral T Cell Lymphoma
    • Pediatric Hodgkin Lymphoma
    • Brentuximab Vedotin (Genetical Recombination)
    • Tokyo, Japan
      Takeda Selected Site
    Oct 11, 2022

    Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      Apr 21, 2023

      Safety and Efficacy of Trastuzumab BS

      Not yet recruiting
      • Gastric Cancer
      • TRASTUZUMAB BS
      • (no location specified)
      Dec 19, 2022

      ATGAM General Investigation

      Not yet recruiting
      • Aplastic Anemia
      • Anti-human thymocyte immunoglobulin, equine
      • (no location specified)
      Sep 8, 2023

      Diabetes Trial in St. John's (AlloRx)

      Recruiting
      • Diabetes
      • AlloRx
      • St. John's, Antigua and Barbuda
      • +2 more
      Oct 21, 2022

      Multiple Sclerosis Trial in St. John's (AlloRx)

      Recruiting
      • Multiple Sclerosis
      • AlloRx
      • St. John's, Antigua and Barbuda
      • +2 more
      Oct 25, 2022

      Rheumatoid Arthritis Trial in St. John's (AlloRx)

      Recruiting
      • Rheumatoid Arthritis
      • AlloRx
      • St. John's, Antigua and Barbuda
      • +2 more
      Oct 25, 2022

      IBD Trial in St. John's (AlloRx)

      Recruiting
      • Inflammatory Bowel Diseases
      • AlloRx
      • St. John's, Antigua and Barbuda
      • +2 more
      Oct 25, 2022

      Renal Impairment Trial in Miskolc (BV100)

      Completed
      • Renal Impairment
      • Miskolc, Hungary
        CRU Hungary Kft., Early Phase Unit
      Jan 16, 2023

      Brentuximab Vedotin Intravenous Infusion "Untreated

      Active, not recruiting
      • Untreated CD30-Positive Hodgkin's Lymphoma
      • Brentuximab vedotin (Genetical Recombination)
      • Tokyo, Japan
        Takeda Selected Site
      Mar 24, 2022

      Pulmonary Hypertension Due to Left Heart Disease Trial in Neu-Ulm (BAY2701250 IV, Placebo IV, BAY2701250 SC)

      Recruiting
      • Pulmonary Hypertension Due to Left Heart Disease
      • BAY2701250 IV
      • +3 more
      • Neu-Ulm, Bayern, Germany
        NUVISAN GmbH Neu-Ulm
      Sep 19, 2023